Annual ROE
-227.95%
-139.05%-156.41%
December 31, 2023
Summary
- As of February 12, 2025, SYRS annual return on equity is -227.95%, with the most recent change of -139.05% (-156.41%) on December 31, 2023.
- During the last 3 years, SYRS annual ROE has fallen by -128.93% (-130.21%).
- SYRS annual ROE is now -922.20% below its all-time high of -22.30%, reached on December 31, 2014.
Performance
SYRS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-2746.84%
-1893.50%-221.89%
September 30, 2024
Summary
- As of February 12, 2025, SYRS quarterly return on equity is -2746.84%, with the most recent change of -1893.50% (-221.89%) on September 30, 2024.
- Over the past year, SYRS quarterly ROE has dropped by -2635.93% (-2376.64%).
- SYRS quarterly ROE is now -4447.75% below its all-time high of -60.40%, reached on September 30, 2017.
Performance
SYRS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SYRS ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -156.4% | -2376.6% |
3 y3 years | -130.2% | -2593.5% |
5 y5 years | -163.4% | -2593.5% |
SYRS ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -156.4% | at low | -3465.0% | at low |
5 y | 5-year | -156.4% | at low | -3465.0% | at low |
alltime | all time | -922.2% | at low | -4447.8% | at low |
Syros Pharmaceuticals ROE History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -2746.84%(+221.9%) |
Jun 2024 | - | -853.34%(+108.6%) |
Mar 2024 | - | -409.15%(+79.3%) |
Dec 2023 | -227.95%(+156.4%) | -228.14%(+105.7%) |
Sep 2023 | - | -110.91%(+9.2%) |
Jun 2023 | - | -101.59%(-0.4%) |
Mar 2023 | - | -101.98%(-6.1%) |
Dec 2022 | -88.90%(-9.7%) | -108.58%(-20.9%) |
Sep 2022 | - | -137.24%(+4.1%) |
Jun 2022 | - | -131.88%(+44.5%) |
Mar 2022 | - | -91.29%(+18.5%) |
Dec 2021 | -98.49%(-0.5%) | -77.05%(-13.3%) |
Sep 2021 | - | -88.89%(-1.4%) |
Jun 2021 | - | -90.16%(-5.4%) |
Mar 2021 | - | -95.27%(-19.6%) |
Dec 2020 | -99.02% | -118.49%(+15.4%) |
Sep 2020 | - | -102.66%(+17.9%) |
Jun 2020 | - | -87.07%(-2.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2020 | - | -89.39%(+1.5%) |
Dec 2019 | -95.63%(+10.5%) | -88.07%(+6.0%) |
Sep 2019 | - | -83.05%(+9.2%) |
Jun 2019 | - | -76.06%(+6.6%) |
Mar 2019 | - | -71.32%(+3.5%) |
Dec 2018 | -86.55%(+16.9%) | -68.90%(+4.6%) |
Sep 2018 | - | -65.88%(+2.5%) |
Jun 2018 | - | -64.30%(-7.5%) |
Mar 2018 | - | -69.52%(-0.7%) |
Dec 2017 | -74.02%(-11.1%) | -70.01%(+15.9%) |
Sep 2017 | - | -60.40%(-6.8%) |
Jun 2017 | - | -64.79%(-4.5%) |
Mar 2017 | - | -67.82%(-8.3%) |
Dec 2016 | -83.28%(+31.7%) | -73.96%(-5.7%) |
Sep 2016 | - | -78.41%(-5.3%) |
Jun 2016 | - | -82.77%(+13.1%) |
Mar 2016 | - | -73.16%(-16.5%) |
Dec 2015 | -63.25%(+183.6%) | -87.57% |
Dec 2014 | -22.30% | - |
FAQ
- What is Syros Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual ROE year-on-year change?
- What is Syros Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly ROE year-on-year change?
What is Syros Pharmaceuticals annual return on equity?
The current annual ROE of SYRS is -227.95%
What is the all time high annual ROE for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual return on equity is -22.30%
What is Syros Pharmaceuticals annual ROE year-on-year change?
Over the past year, SYRS annual return on equity has changed by -139.05% (-156.41%)
What is Syros Pharmaceuticals quarterly return on equity?
The current quarterly ROE of SYRS is -2746.84%
What is the all time high quarterly ROE for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly return on equity is -60.40%
What is Syros Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, SYRS quarterly return on equity has changed by -2635.93% (-2376.64%)